248 related articles for article (PubMed ID: 30258109)
21. An novel inhibitor of TGF-β type I receptor, IN-1130, blocks breast cancer lung metastasis through inhibition of epithelial-mesenchymal transition.
Park CY; Min KN; Son JY; Park SY; Nam JS; Kim DK; Sheen YY
Cancer Lett; 2014 Aug; 351(1):72-80. PubMed ID: 24887560
[TBL] [Abstract][Full Text] [Related]
22. ILEI drives epithelial to mesenchymal transition and metastatic progression in the lung cancer cell line A549.
Song Q; Sheng W; Zhang X; Jiao S; Li F
Tumour Biol; 2014 Feb; 35(2):1377-82. PubMed ID: 24072492
[TBL] [Abstract][Full Text] [Related]
23. AHNAK Loss in Mice Promotes Type II Pneumocyte Hyperplasia and Lung Tumor Development.
Park JW; Kim IY; Choi JW; Lim HJ; Shin JH; Kim YN; Lee SH; Son Y; Sohn M; Woo JK; Jeong JH; Lee C; Bae YS; Seong JK
Mol Cancer Res; 2018 Aug; 16(8):1287-1298. PubMed ID: 29724814
[TBL] [Abstract][Full Text] [Related]
24. Regulation of complement-dependent cytotoxicity by TGF-β-induced epithelial-mesenchymal transition.
Goswami MT; Reka AK; Kurapati H; Kaza V; Chen J; Standiford TJ; Keshamouni VG
Oncogene; 2016 Apr; 35(15):1888-98. PubMed ID: 26148233
[TBL] [Abstract][Full Text] [Related]
25. TGFβ induces epithelial-mesenchymal transition of thyroid cancer cells by both the BRAF/MEK/ERK and Src/FAK pathways.
Baquero P; Jiménez-Mora E; Santos A; Lasa M; Chiloeches A
Mol Carcinog; 2016 Nov; 55(11):1639-1654. PubMed ID: 26392228
[TBL] [Abstract][Full Text] [Related]
26. Epithelial-Mesenchymal Transition and Metastasis under the Control of Transforming Growth Factor β.
Tsubakihara Y; Moustakas A
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30463358
[TBL] [Abstract][Full Text] [Related]
27. Reprogramming during epithelial to mesenchymal transition under the control of TGFβ.
Tan EJ; Olsson AK; Moustakas A
Cell Adh Migr; 2015; 9(3):233-46. PubMed ID: 25482613
[TBL] [Abstract][Full Text] [Related]
28. Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent TGFβ receptor degradation in breast cancer.
Hsu HY; Lin TY; Hwang PA; Tseng LM; Chen RH; Tsao SM; Hsu J
Carcinogenesis; 2013 Apr; 34(4):874-84. PubMed ID: 23275155
[TBL] [Abstract][Full Text] [Related]
29. Role of the focal adhesion protein kindlin-1 in breast cancer growth and lung metastasis.
Sin S; Bonin F; Petit V; Meseure D; Lallemand F; Bièche I; Bellahcène A; Castronovo V; de Wever O; Gespach C; Lidereau R; Driouch K
J Natl Cancer Inst; 2011 Sep; 103(17):1323-37. PubMed ID: 21832234
[TBL] [Abstract][Full Text] [Related]
30. Downregulating HMGA2 attenuates epithelial-mesenchymal transition-induced invasion and migration in nasopharyngeal cancer cells.
Xia YY; Yin L; Jiang N; Guo WJ; Tian H; Jiang XS; Wu J; Chen M; Wu JZ; He X
Biochem Biophys Res Commun; 2015 Jul; 463(3):357-63. PubMed ID: 26025649
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-182 targets SMAD7 to potentiate TGFβ-induced epithelial-mesenchymal transition and metastasis of cancer cells.
Yu J; Lei R; Zhuang X; Li X; Li G; Lev S; Segura MF; Zhang X; Hu G
Nat Commun; 2016 Dec; 7():13884. PubMed ID: 27996004
[TBL] [Abstract][Full Text] [Related]
32. Paeonol inhibits B16F10 melanoma metastasis in vitro and in vivo via disrupting proinflammatory cytokines-mediated NF-κB and STAT3 pathways.
Zhang L; Tao L; Shi T; Zhang F; Sheng X; Cao Y; Zheng S; Wang A; Qian W; Jiang L; Lu Y
IUBMB Life; 2015 Oct; 67(10):778-88. PubMed ID: 26452780
[TBL] [Abstract][Full Text] [Related]
33. TGFβ selects for pro-stemness over pro-invasive phenotypes during cancer cell epithelial-mesenchymal transition.
Tsubakihara Y; Ohata Y; Okita Y; Younis S; Eriksson J; Sellin ME; Ren J; Ten Dijke P; Miyazono K; Hikita A; Imamura T; Kato M; Heldin CH; Moustakas A
Mol Oncol; 2022 Jun; 16(12):2330-2354. PubMed ID: 35348275
[TBL] [Abstract][Full Text] [Related]
34. Discovery of a natural small-molecule compound that suppresses tumor EMT, stemness and metastasis by inhibiting TGFβ/BMP signaling in triple-negative breast cancer.
Di L; Liu LJ; Yan YM; Fu R; Li Y; Xu Y; Cheng YX; Wu ZQ
J Exp Clin Cancer Res; 2019 Mar; 38(1):134. PubMed ID: 30898152
[TBL] [Abstract][Full Text] [Related]
35. A kinome-wide high-content siRNA screen identifies MEK5-ERK5 signaling as critical for breast cancer cell EMT and metastasis.
Pavan S; Meyer-Schaller N; Diepenbruck M; Kalathur RKR; Saxena M; Christofori G
Oncogene; 2018 Aug; 37(31):4197-4213. PubMed ID: 29713055
[TBL] [Abstract][Full Text] [Related]
36. Autophagy regulates transforming growth factor β signaling and receptor trafficking.
Trelford CB; Di Guglielmo GM
Biochim Biophys Acta Mol Cell Res; 2022 Sep; 1869(9):119284. PubMed ID: 35605790
[TBL] [Abstract][Full Text] [Related]
37. Growth hormone is increased in the lungs and enhances experimental lung metastasis of melanoma in DJ-1 KO mice.
Chien CH; Lee MJ; Liou HC; Liou HH; Fu WM
BMC Cancer; 2016 Nov; 16(1):871. PubMed ID: 27825319
[TBL] [Abstract][Full Text] [Related]
38. Role of BCL9L in transforming growth factor-β (TGF-β)-induced epithelial-to-mesenchymal-transition (EMT) and metastasis of pancreatic cancer.
Sannino G; Armbruster N; Bodenhöfer M; Haerle U; Behrens D; Buchholz M; Rothbauer U; Sipos B; Schmees C
Oncotarget; 2016 Nov; 7(45):73725-73738. PubMed ID: 27713160
[TBL] [Abstract][Full Text] [Related]
39. EGCG inhibits transforming growth factor-β-mediated epithelial-to-mesenchymal transition via the inhibition of Smad2 and Erk1/2 signaling pathways in nonsmall cell lung cancer cells.
Liu LC; Tsao TC; Hsu SR; Wang HC; Tsai TC; Kao JY; Way TD
J Agric Food Chem; 2012 Oct; 60(39):9863-73. PubMed ID: 22957988
[TBL] [Abstract][Full Text] [Related]
40. MiR-145 and miR-203 represses TGF-β-induced epithelial-mesenchymal transition and invasion by inhibiting SMAD3 in non-small cell lung cancer cells.
Hu H; Xu Z; Li C; Xu C; Lei Z; Zhang HT; Zhao J
Lung Cancer; 2016 Jul; 97():87-94. PubMed ID: 27237033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
